In vivo production of nitric oxide in rats after administration of hydroxyurea

Molecular Pharmacology

Volumn 52, Issue 6, 1997, Pages 1081-1085

  Jiang, Jinjie ^a   Jordan, Sandra J ^a   Barr, David P ^a   Gunther, Michael R ^a   Maeda, Hiroshi ^b   Mason, Ronald P ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

^b KUMAMOTO UNIV SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROXYUREA; NITRIC OXIDE; NITROPRUSSIDE SODIUM; VASODILATOR AGENT;

ANIMAL TISSUE; ANTINEOPLASTIC ACTIVITY; ARTICLE; DNA SYNTHESIS; DRUG METABOLISM; NONHUMAN; PRIORITY JOURNAL; RAT; SICKLE CELL ANEMIA; TUMOR;

EID: 0031468478     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.52.6.1081     Document Type: Article

References (40)

1. Dressler, W. F. C., and R. Stein. Uber den Hydroxylharnstoff. Justus Liebigs Ann. Chem. 150:242-252 (1869).
2. Yarbro, J. W., B. J. Kennedy, and C. P. Barnum. Hydroxyurea inhibition of DNA synthesis in ascites tumor. Proc. Natl. Acad. Sci. USA 53:1033-1035 (1965).
3. Krakoff, I. H., N. C. Brown, and P. Reichard. Inhibition of ribonucleotide diphosphate reductase by hydroxyurea. Cancer Res. 28:1559-1565 (1968).
4. Nyholm, S., L. Thelander, and A. Graslund. Reduction and loss of the iron center in the reaction of the small subunit of mouse ribonucleotide reductase with hydroxyurea. Biochemistry 32:11569-11574 (1993).
5. Boyd, A. S., and K. H. Neldner. Hydroxyurea therapy. J. Am. Acad. Dermatol. 25:518-524 (1991).
6. Layton, A. M., R. A. Sheehan-Dare, M. J. Goodfield, and J. A. Cotterill. Hydroxyurea in the management of therapy resistant psoriasis. Br. J. Dermatol. 121:647-653 (1989).
7. Piver, M., M. Khalil, and L. J. Emrich. Hydroxyurea plus pelvic irradiation versus placebo plus pelvic irradiation in nonsurgically tagged stage IIIB cervical cancer. J. Surg. Oncol. 42:120-125 (1989).
8. Rodgers, G. P., G. J. Dover, C. T. Noguchi, A. N. Schecter, and A. W. Nienhuis. Hematologic responses of patients with sickle cell disease to treatment with hydroxyurea. N. Engl. J. Med. 322:1037-1045 (1990).
9. Orringer, E. P., and J. C. Parker. Hydroxyurea and sickle cell disease. Hematol. Pathol. 6:171-178 (1992).
10. Donehower, R. C. Hydroxyurea, in Pharmacologic Principles of Cancer Treatment (B. A. Chabner, ed.). W. B. Saunders, Philadelphia, 269-275 (1982).
11. Kwon, N. S., D. J. Stuehr, and C. F. Nathan. Inhibition of tumor cell ribonucleotide reductase by microphage-derived nitric oxide. J. Exp. Med. 174:761-767 (1991).
12. Feelisch, M., and J. S. Stamler. Donors of nitrogen oxides, in Methods in Nitric Oxide Research (M. Feelisch and J. S. Stamler, eds.). John Wiley & Sons, Chichester, England, 72-115 (1996).
13. Bauer, J. A., B. P. Booth, and H. L. Fung. Nitric oxide donors: biochemical pharmacology and therapeutics. Adv. Pharmacol. 34:361-381 (1995).
14. Ingarro, L. J., H. Lippton, J. C. Edwards, W. H. Baricos, A. L. Hyman, P. J. Kadowitz, and C. A. Gruetter. Mechanism of vascular smooth muscle relaxation by organic nitrates, nitrites, nitroprusside, and nitric oxide: evidence for the involvement of S-nitrosothiols as active intermediates. J. Pharmacol. Exp. Ther. 218:739-749 (1981).
15. Hooper, A. B., and K. R. Terry. Hydroxylamine oxidoreductase of nitrosomonas production of nitric oxide from hydroxylamine. Biochem. Biohpys. Acta. 571:12-20 (1979).
16. Markert, M., B. Carnal, and J. Mauel. Nitric oxide production by activated human neutrophils exposed to sodium azide and hydroxylamine: the role of oxygen radicals. Biochem. Biophys. Res. Commun. 199:1245-1249 (1994).
17. Il'yasova, V. B., A. A. Buzukov, M. Tabak, and I. A. Degterev. Mechanism of metabolic denitration of nitroheterocyclic compounds. Biophysics 39: 219-225 (1994).
18. Mason, R. P., and P. D. Josephy. An electron spin resonance investigation of the iron-catalyzed reaction of metronidazole with cysteine. J. Inorg. Biochem. 24:161-165 (1985).
19. Myers, L. A., C. M. Witmer, and M. A. Gallo. Characterization and identification of an indirect cytochrome p-450-itiniated denitrosation of 2,6-dichloro-4-nitroaniline in rat hepatic microsomes. Toxicol. Appl. Pharmacol. 95:139-152 (1988).
20. Singel, D. J., and J. R. Lancaster, Jr. Electron paramagnetic resonance spectroscopy and nitric oxide biology, in Methods in Nitric Oxide Research (M. Feelisch and J. S. Stamler, eds.). John Wiley & Sons, Chichester, England, 341-356 (1996).
21. Murphy, M. E., and E. Noack. Nitric oxide assay using hemoglobin method. Methods Enzymol. 233:240-250 (1994).
22. Henry, Y. A., and D. J. Singel. Metal-nitrosyl interactions in nitric oxide biology probed by electron paramagnetic resonance spectroscopy, in Methods in Nitric Oxide Research (M. Feelisch and J. S. Stamler, eds.). John Wiley & Sons, Chichester, England, 357-372 (1996).
23. Kon, H., and N. Kataoka. Electron paramagnetic resonance of nitric oxide-protoheme complexes with some nitrogenous base. Model systems of nitric oxide hemoproteins. Biochemistry 8:4757-4762 (1969).
24. Yonetani, T., H. Yamamoto, J. E. Erman, J. S. Leigh, Jr., and G. H. Reed. Electromagnetic properties of hemoproteins. V. Optical and electron paramagnetic resonance characteristics of nitric oxide derivatives of metalloporphyrin-apohemoprotein complexes. J. Biol. Chem. 247:2447-2455 (1972).
25. Henry, Y., C. Ducrocq, J.-C. Drapier, D. Servent, C. Pellat, and A. Guissani. Nitric oxide, a biological effector. Eur. Biophys. J. 20:1-15 (1991).
26. Kosaka, H., and T. Shiga. Nitric oxide hemoglobin detected by ESR in septic shock model, in Frontiers of Reactive Oxygen Species in Biology and Medicine (K. Asada and T. Yoshikawa, eds.). Elsevier Science B.V., Amsterdam, The Netherlands, 211-214 (1994).
27. Chamulitrat, W., S. J. Jordan, and R. P. Mason. Nitric oxide production during endotoxic shock in carbon tetrachloride-treated rats. Mol. Pharmacol. 46:391-397 (1994).
28. Kumura, E., T. Yoshimine, S. Tanaka, T. Hayakawa, T. Shiga, and H. Kosaka. Nitrosyl hemoglobin production during reperfusion after focal cerebral ischemia in rats. Neurosci. Lett. 177:165-167 (1994).
29. Konorev, E. A., J. Joseph, and B. Kalyanaraman. S-Nitrosoglutathione induces formation of nitrosylymyoglobin in isolated hearts during cardioplegic ischemia - an electron spin resonance study. FEBS Lett. 378: 111-114 (1996).
30. Lassmann, G., and B. Liermann. ESR studies of structure and kinetics of radicals from hydroxyurea. An antitumor drug directed against ribonucleotide reductase. Free Radical Biol. Med. 6:241-244 (1989).
31. Stolze, K., and H. Nohl. EPR studies on the oxidation of hydroxyurea to paramagnetic compounds by oxyhemoglobin. Biochem. Pharmacol. 40: 799-802 (1990).
32. Balint, J., G. Horvath, A. Meynhart, L. Pinter, and A. Tomor, inventors. Biogal Gyogyszergyar, Hungary, assignee. Hydroxy urea prepn - by reacting alkali metal cyancate and hydroxylamine over weakly basic ion exchange resin. Patent #HU 10171 (1975).
33. Caughey, W. S., and J. A. Watkins. Oxy radical and peroxide formation by hemoglobin and myoglobin, in CAC Handbook of Methods for Oxygen Radical Research (R. A. Greenwald, ed.). CRC Press, Boca Raton, FL, 95-104 (1985).
34. Di Iorio, E. E. Preparation of derivatives of ferrous and ferric hemoglobin. Methods Enzymol. 76:57-72 (1981).
35. Kosaka, H., and T. Shiga. Detection of nitric oxide by electron spin resonance using hemoglobin, in Methods in Nitric Oxide Research (M. Feelisch and J. S. Stamler, eds.). John Wiley & Sons, Chichester, England, 373-381 (1996).
36. Wertz, J. E., and J. R. Bolton. Electron Spin Resonance. Elementary Theory and Practical Applications. McGraw-Hill, New York, 40-43 (1972).
37. Morgan, J. S., D. C. Creasey, and J. A. Wright. Evidence that the antitumor agent hydroxyurea enters mammalian cells by a diffusion mechanism. Biochem. Biophys. Res. Commun. 134:1254-1259 (1986).
38. Pacelli, R., J. Taira, J. A. Cook, D. A. Wink, and M. C. Krishna. Hydroxyurea reacts with heme proteins to generate nitric oxide. Lancet 347:900 (1996).
39. Chamulitrat, W., R. P. Mason, and D. Riendeau. Nitroxide metabolites from alkylhydroxylamines and N-hydroxyurea derivatives resulting from reductive inhibition of soybean lipoxygenase. J. Biol. Chem. 267:9574-9579 (1992).
40. Lassmann, G., L. Thelander, and A. Graslund. EPR stopped-flow studies of the reaction of the tyrosol radical of protein R2 from ribonucleotide reductase with hydroxyurea. Biochem. Biophys. Res. Commun. 188:879-887 (1992).